Click to watch the live stream and join the conversation. #PhRMA16

0 SHARES

0

0

0

6

0 SHARES

0

0

0

6

People Behind the Science

Learn about the men and women dedicated to bringing new treatments and cures to patients.


Researching and developing innovative medicines is a challenging undertaking – and the science is only getting harder. America’s biopharmaceutical researchers and scientists are committed to persevering in the face of setbacks to bring new and innovative medicines to patients. See their stories below.

    • The 20-year journey yielding a new weapon against cancer

      AbbVie researchers share their experiences, the challenges they faced and why the ability to harness BCL-2 to fight cancer is so important.

      Watch the Video
    • Translating science into new medicines

      Luciano Rossetti, M.D. explains the commitment it takes for researchers and scientists to achieve breakthroughs in cancer medicines.

      Watch the Video
    • Building on the promise of personalized medicine

      Dr. Bernie Zeiher, president of development of Astellas, discusses his excitement around personalized medicine, which uses diagnostic tools to assess medical treatments and procedures that are best for each patient.

      Watch the Video
    • Dr. George Scangos: Not Just Science for Science’s Sake

      America’s biopharmaceutical researchers and scientists like Dr. George Scangos are working tirelessly to develop new and innovative medicines for patients, particularly neurological diseases, like Alzheimer’s.

      Watch the Video
    • Science of Hope: Incorporating the patient perspective

      Dr. Al Sandrock, chief medical officer at Biogen, shares his experiences working in the biopharmaceutical industry, and how first-hand accounts from patients motivate him every day.

      Watch the Video
    • Advancing the Science of Hope

      Thanks to scientists and researchers like Jen, there are 836 medicines and vaccines in development for cancer.

      Watch the Video
    • Targeting the immune system, not the tumor

      Immuno-oncology is based on the concept of harnessing the body’s own immune system to fight cancer.

      Watch the Video
    • Helping patients is what drives America’s biopharmaceutical researchers and scientists

      Dr. Michael Rosenblatt, chief medical officer at Merck, along with countless others in the health care ecosystem, are working tirelessly each and every day to help address the remaining unmet medical needs for patients.

      Watch the Video
    • America’s biopharmaceutical industry is central to diverse R&D ecosystem

      Dr. Tim Garnett, chief medical officer at Eli Lilly and Company underscores that developing innovative, lifesaving medicines for patients is the sole focus of the biopharmaceutical industry.

      Watch the Video
    • Research Doesn't End on a Medicine's Approval

      Research on a medicine doesn’t end on the initial approval by the FDA. Eli Lilly and Company’s chief medical officer shares why ongoing research helps us better understand a medicines full value.

      Watch the Video
    • Antibody Drug Conjugates

      ADCs are the next wave of targeted cancer treatment. Toxins that can target tumors while sparing healthy cells are now a reality in the fight against cancer.

      Watch the Video
    • Creating Medicines Also Creates Jobs: Sheet Metal Workers Explain

      To create top of the line development facilities, Merck collaborates with highly trained Sheet Metal Workers from Local Union No. 19 in Philadelphia.

      Watch the Video
    • Sean Pintchovski, Lundbeck

      "On any given day, there's the possibility that I may be the very first person to learn and understand how something in the brain works. That's an exhilarating and rare feeling!"

      Watch the Video
    • Michelle Seng, EMD Serono

      Explore a day in the life of biopharmaceutical scientist Michelle Seng.

      Watch the Video
    • Meredith Liberto, Boehringer-Ingelheim

      "When you put a human face to the disease, it puts drug discovery into perspective. I always feel most inspired after speaking with patients and their advocates."

      Watch the Video
    • Dowdy Jackson, Agensys

      "There is always that hope that the medicine you are working on will allow a cancer patient more time with their families."

      Watch the Video
    • Olof Larsson, Eli Lilly and Company

      Explore a day in the life of Chief Scientific Officer Olof Larsson of Eli Lilly and Company.

      Watch the Video
    • Pat Scannon, Xoma

      Explore a day in the life of Chief Scientific Officer Pat Scannon of Xoma.

      Watch the Video
    • Samantha Budd, AstraZeneca

      "I am motivated by the challenge, the complexity, and the intellectual powerhouse we need to bring to make the breakthroughs and what they can mean for patients' lives."

      Watch the Video
    • Misty Vest, Agensys

      "I often think about how the work really never ends. Research is exactly what it means: the search for answers over and over again until you find exactly the desired outcome. There are so many questions out there, but also so many answers."

      Watch the Video
    • John Corbin, Xoma

      Explore a day in the life of biopharmaceutical scientist John Corbin.

      Watch the Video
    • Michael Ehlers, Pfizer

      "Science is always full of surprises. Unexpected findings occur all the time and half my job is recognizing new areas of opportunity and making decisions around the most promising next experiment."

      Watch the Video

connect with PhRMA...

Make your voice heard. Join the important discussion on the value and economic impact of new medicines.


connect with PhRMA...

Make your voice heard. Join the important discussion on the value and economic impact of new medicines.


  • +68K

    Followers

  • +57K

    Followers

  • 366

    Followers

  • 3343

    Subscribers